Buy Charter Communications 5.05% 2029 (bond) Presented Nov 13, 2026

Charter Communications Bonds

Pearce Campbell, Charles Anderson, Brooke Weiss, Millie McFadden, George Logan, Thomas McElwain, Campbell Goodwin, Riker Slack

Charter's senior secured 5.05% notes due March 2029, bought below par for a 6.20% yield to maturity. The case is to put idle cash to work and offset SIG's 42% tech weighting, backed by Charter's free cash flow, its pause on buybacks to pay down debt, and a maturity that comes before its 2030 'debt wall'. Risks covered: refinancing, reinvestment, default and price risk.

Proposal

  • Buy 8 bonds ($8,000 face value) at $975.00 each (about $7,800), returning $8,000 at maturity plus about $1,010 in interest

Executed

  • Nov 12, 2026: bought $2,000 face value (2 bonds) at 97.50% of par ($1,950.00)
  • Nov 16, 2026: bought $6,000 face value (6 bonds) at 97.41% of par ($5,844.76)

Current position: 161175BR4: $8,000 face value held

Sell SRVR Presented Nov 13, 2026

Pacer Data & Infrastructure Real Estate ETF

Millie McFadden, Pearce Campbell

SRVR is concentrated in communications-infrastructure and data-center REITs with low growth expectations and heavy debt that constrains cash flow. The fund has lagged the overall market for years, few analysts see meaningful upside, and like any REIT it returns capital mostly through dividends rather than price gains, which doesn't fit a growth-oriented portfolio.

Proposal

  • Sell all 96.385 shares at $28.58 (about $2,754), a 0.38% loss on cost

Executed

  • Nov 17, 2026: sold 98.3676 SRVR at $27.81 ($2,735.92)

Current position: SRVR: not held

Sell IBM Presented Nov 13, 2026

IBM (International Business Machines)

Franklin Custard

IBM trades about 25% below its 52-week high of $332.46, guides to only 4–5% revenue growth for 2026, and saw flat consulting revenue and a 20% drop in mainframe revenue in Q3. Long-term debt has risen from $44.9 billion in 2021 to $56.2 billion, dividend growth is about 0.6% a year, and a forward P/E of 19.4 leaves little cushion. Selling frees capital for higher-growth AI and tech holdings.

Proposal

  • Sell all shares at $253.44 (about $3,208), a gain of about $1,436

Executed

  • Nov 17, 2026: sold 12.7462 IBM at $238.66 ($3,041.99)

Current position: IBM: not held

Buy SPCX Presented Oct 27, 2026

SpaceX

Pearce Campbell, Jack Johnson

Growth case built on Starlink, launch operations and SpaceX's AI plans, including space-based data centers and in-house chips. Risks covered: AI-industry volatility, government contracts, launch regulation and Elon Musk's voting control.

Proposal

  • Buy 68 shares at $147 (about $10,143, roughly 3.8% of the portfolio)

Executed

  • Nov 2, 2026: bought 68 SPCX at $140.82 ($9,575.76)

Current position: SPCX: 68 shares held

Sell Disney · Lululemon · AT&T · UnitedHealth Presented Oct 27, 2026

DIS · LULU · T · UNH

Pearce Campbell, Thomas McElwain, Brooke Weiss, Millie McFadden, Charles Anderson, Campbell Goodwin, George Logan, Riker Slack

Four sell cases from the Oct 27 meeting: Disney's low growth and debt load, Lululemon's shrinking revenue, AT&T's leverage and slow growth, and closing out a $4 UnitedHealth position.

Proposals

  • Sell 25 shares of Disney (about $2,743)
  • Sell 5 shares of Lululemon (about $515)
  • Sell 147.42 shares of AT&T (about $3,074)
  • Sell 0.01 shares of UnitedHealth (about $4)

Executed

  • Nov 2, 2026: sold 25.036 DIS at $113.10 ($2,831.57)
  • Nov 2, 2026: sold 5 LULU at $109.52 ($547.60)
  • Nov 2, 2026: sold 147.4221 T at $21.55 ($3,176.95)
  • Nov 2, 2026: sold 0.0101 UNH at $396.26 ($4.00)

Current position: DIS: not held · LULU: not held · T: not held · UNH: not held

Sell SOFI Presented Oct 27, 2026

SoFi

Jacob Campbell, Auggie Albers, AP Bryan

Stock down about 41% year to date, negative free cash flow in FY2025, and exposure to interest-rate and personal-loan credit risk.

Proposal

  • Sell all 120 shares at $14.62 (about $1,754), a 12.2% loss on cost

Executed

  • Nov 2, 2026: sold 120 SOFI at $17.43 ($2,091.60)

Current position: SOFI: not held

Buy NVS Presented Oct 27, 2026

Novartis

Minh Nguyen

Novartis is now a pure drug maker focused on heart and kidney disease, cancer, immune disorders, and brain and nerve disease. The case rests on fast-growing newer drugs (Kisqali, Pluvicto, Leqvio, Scemblix), its 5–6% yearly sales growth target for 2025–2030, steady demand for medicine in any economy, a dividend of about 3.1%, and diversification away from SIG's tech-heavy holdings into a non-US company. Risks covered: generic competition for older drugs such as Entresto, flat 2026 profit guidance, two late-stage trial failures in September 2026, and US drug-price policy.

Proposal

  • Buy 24 shares at $151.12 (about $3,627, 1.4% of the portfolio), placed after the Oct 27 Q3 report unless Novartis cuts its 5–6% yearly sales growth target for 2025–2030

Executed

  • Nov 2, 2026: bought 24 NVS at $160.56 ($3,853.44)

Current position: NVS: 24 shares held

Buy AAPL Presented Oct 16, 2026

Apple

Pearce Campbell, Thomas McElwain, Brooke Weiss, Millie McFadden, Charles Anderson, Campbell Goodwin, George Logan, Riker Slack

Case for adding to Apple: FY2026 revenue estimated at $479 billion (up 15%), a $100 billion buyback, growing free cash flow, new CEO John Ternus's product plans, and a lower-cost approach to AI.

Proposal

  • Buy 22 more shares at about $342 (about $7,500)

Executed

  • Oct 19, 2026: bought 22 AAPL at $343.36 ($7,553.92)

Current position: AAPL: 32.2988 shares held

Sell TMUS Presented Oct 16, 2026

T-Mobile

Jacob Campbell

A solid company with limited room to grow: rising debt without major new projects, and the stock down about 21% year to date.

Proposal

  • Sell all 7.6 shares at $161.53 (about $1,228), a 7.5% gain on cost

Executed

  • Oct 19, 2026: sold 7.3232 TMUS at $157.72 ($1,155.04)

Current position: TMUS: not held

Sell META Presented Sep 17, 2026

Meta Platforms

Pearce Campbell, Jack Johnson

Solid fundamentals (revenue up from $118 billion in FY21 to $201 billion in FY25) but large risks ahead: about $420 billion in off-balance-sheet data-center financing, capital spending projected at $130–145 billion for 2026, and data-center assets that will need to be depreciated if AI growth slows. DCF models put fair value around $650–680, so selling near that level gives up little upside. Risks also covered: past cost overruns at Reality Labs and regulation.

Proposal

  • Sell all 8.6 shares at $670 (about $5,408), a 103% gain on the $329.40 cost per share (about $2,658)

Executed

  • Sep 22, 2026: sold 8.0698 META at $748.81 ($6,042.62)

Current position: META: not held